Peer-influenced content. Sources you trust. No registration required. This is HCN.

Trending Topics:
DIET & NUTRITION PATIENT EDUCATION OBESITY/WEIGHT MANAGEMENT EXERCISE/TRAINING LEGAL MATTERS GUIDELINES/RECOMMENDATIONS

Articles related to MOVEMENT DISORDERS

Psychiatry Advisor

VMAT2 Inhibitors Reduce Risk for Adverse Outcomes in Tardive Dyskinesia

VMAT2 inhibitors were associated with lower rates of falls, injuries, fractures, and several secondary adverse outcomes than anticholinergic agents in a propensity-matched cohort of adults with tardive dyskinesia.

Neurology May 13th 2026

Tags: ADVERSE EVENTS ANTIPSYCHOTICS DEPRESCRIBING DRUG SAFETY & INTERACTIONS MOVEMENT DISORDERS PHARMACOTHERAPY TARDIVE DYSKINESIA (TD)

Parkinson’s News Today

AAN 2026: Crexont Linked to More on Time in New Parkinson’s Study

Switching Parkinson’s patients to Crexont added more than three hours of daily symptom control in interim Phase 4 data. Here’s how to read an open-label, sponsor-run signal.

Neurology April 30th 2026

Tags: DRUG FORMULATION MOVEMENT DISORDERS PARKINSON'S DISEASE (PD) PATIENT ADHERENCE PHARMACOTHERAPY QUALITY OF LIFE REAL-WORLD EVIDENCE RESEARCH & CLINICAL TRIALS SYMPTOM MANAGEMENT

Parkinson’s News Today

Fecal Transplants Ease Motor Symptoms in Early Parkinson’s

Repeated fecal transplants improved motor symptoms and constipation in early Parkinson’s, highlighting the gut microbiome as a potential therapeutic research pathway.

Gastroenterology April 15th 2026

Tags: GUT-BRAIN AXIS MICROBIOME RESEARCH MOTOR FUNCTION MOVEMENT DISORDERS NON-MOTOR SYMPTOMS PARKINSON'S DISEASE (PD)

Parkinson’s News Today

FDA Grants Advanced Therapy Status to Parkinson’s Cell Treatment

Twelve months after transplantation with the lower dose, mean scores decreased by 30.6 points during off time (a 52.82% improvement from baseline) and by 12.9 points during on time (a 54.67% improvement).

Geriatrics February 5th 2026

Tags: FDA MOVEMENT DISORDERS NEUROSURGERY PARKINSON'S DISEASE (PD) REGULATORY AFFAIRS

MDLinx

Ozzy Osbourne’s Parkinson’s Wasn’t Typical—and Neither Was His Decline

This combination of Parkinsonism and polytrauma provides a powerful example of how neurodegeneration can be compounded by structural damage, with each element worsening the other.

Geriatrics August 20th 2025

Tags: CELEBRITY DIAGNOSIS MOVEMENT DISORDERS NEURODEGENERATIVE DISEASES PARKINSON'S DISEASE (PD)

Medical Professionals Reference (MPR)

FDA Clears AI-Powered Wristband Device for Patients with Essential Tremor

This breakthrough in noninvasive, intelligent, and personalized neuromodulation marks the emergence of AI therapeutics in disease treatment.

Neurology July 23rd 2025

Tags: ARTIFICIAL INTELLIGENCE (AI) DEVICE/DRUG APPROVALS ESSENTIAL TREMOR (ET) MOVEMENT DISORDERS WEARABLES

Topics

Sources

American Journal of Clinical Pathology (AJCP)
American Nurse Journal (ANJ)
Anesthesiology News
Annals of Internal Medicine
British Medical Journal (The BMJ)
Cancer Therapy Advisor
Cardiology Advisor
Cleveland Clinic Journal of Medicine (CCJM)
Clinical Advisor
Conexiant
Consultant360
Cureus
Dermatology Advisor
Endocrinology Advisor
Gastroenterology Advisor
GoodRx for Healthcare Professionals
Healthgrades for Professionals
Hematology Advisor
JNP: The Journal for Nurse Practitioners
Journal of Invasive Cardiology (JIC)
Journal of the American College of Cardiology (JACC)
Journal of the National Cancer Institute (JNCI)
Mayo Clinic
MD Newsline
MDLinx
MedCentral
Medical News Today (MNT)
Medical Professionals Reference (MPR)
Neurology Advisor
Oncology News Central (ONC)
Ophthalmology Advisor
Pharmacy Practice News
Physician’s Weekly
POCN
Practical Neurology
Psychiatrist.com
Psychiatry Advisor
ReachMD
Renal & Urology News
The American Journal of Nursing (AJN)
UCLA Health
WebMD
Women’s Healthcare
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form